questionsmedicales.fr
États, signes et symptômes pathologiques
Processus pathologiques
Processus néoplasiques
Processus néoplasiques : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Processus néoplasiques : Questions médicales les plus fréquentes",
"headline": "Processus néoplasiques : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Processus néoplasiques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-18",
"dateModified": "2025-04-13",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Processus néoplasiques"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Processus pathologiques",
"url": "https://questionsmedicales.fr/mesh/D010335",
"about": {
"@type": "MedicalCondition",
"name": "Processus pathologiques",
"code": {
"@type": "MedicalCode",
"code": "D010335",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Anaplasie",
"alternateName": "Anaplasia",
"url": "https://questionsmedicales.fr/mesh/D000708",
"about": {
"@type": "MedicalCondition",
"name": "Anaplasie",
"code": {
"@type": "MedicalCode",
"code": "D000708",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.727.045"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Carcinogenèse",
"alternateName": "Carcinogenesis",
"url": "https://questionsmedicales.fr/mesh/D063646",
"about": {
"@type": "MedicalCondition",
"name": "Carcinogenèse",
"code": {
"@type": "MedicalCode",
"code": "D063646",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.727.098"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Transformation cellulaire néoplasique",
"alternateName": "Cell Transformation, Neoplastic",
"url": "https://questionsmedicales.fr/mesh/D002471",
"about": {
"@type": "MedicalCondition",
"name": "Transformation cellulaire néoplasique",
"code": {
"@type": "MedicalCode",
"code": "D002471",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.727.098.500"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Crise blastique",
"alternateName": "Blast Crisis",
"url": "https://questionsmedicales.fr/mesh/D001752",
"about": {
"@type": "MedicalCondition",
"name": "Crise blastique",
"code": {
"@type": "MedicalCode",
"code": "D001752",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.727.098.500.110"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Crise blastique",
"alternateName": "Blast Crisis",
"url": "https://questionsmedicales.fr/mesh/D001752",
"about": {
"@type": "MedicalCondition",
"name": "Crise blastique",
"code": {
"@type": "MedicalCode",
"code": "D001752",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.727.098.500.110"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Cocancérogenèse",
"alternateName": "Cocarcinogenesis",
"url": "https://questionsmedicales.fr/mesh/D003043",
"about": {
"@type": "MedicalCondition",
"name": "Cocancérogenèse",
"code": {
"@type": "MedicalCode",
"code": "D003043",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.727.098.750"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Invasion tumorale",
"alternateName": "Neoplasm Invasiveness",
"url": "https://questionsmedicales.fr/mesh/D009361",
"about": {
"@type": "MedicalCondition",
"name": "Invasion tumorale",
"code": {
"@type": "MedicalCode",
"code": "D009361",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.727.645"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Infiltration leucémique",
"alternateName": "Leukemic Infiltration",
"url": "https://questionsmedicales.fr/mesh/D017254",
"about": {
"@type": "MedicalCondition",
"name": "Infiltration leucémique",
"code": {
"@type": "MedicalCode",
"code": "D017254",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.727.645.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Métastase tumorale",
"alternateName": "Neoplasm Metastasis",
"url": "https://questionsmedicales.fr/mesh/D009362",
"about": {
"@type": "MedicalCondition",
"name": "Métastase tumorale",
"code": {
"@type": "MedicalCode",
"code": "D009362",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.727.650"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Extension extranodale",
"alternateName": "Extranodal Extension",
"url": "https://questionsmedicales.fr/mesh/D000079822",
"about": {
"@type": "MedicalCondition",
"name": "Extension extranodale",
"code": {
"@type": "MedicalCode",
"code": "D000079822",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.727.650.280"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Métastase lymphatique",
"alternateName": "Lymphatic Metastasis",
"url": "https://questionsmedicales.fr/mesh/D008207",
"about": {
"@type": "MedicalCondition",
"name": "Métastase lymphatique",
"code": {
"@type": "MedicalCode",
"code": "D008207",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.727.650.560"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Micrométastase tumorale",
"alternateName": "Neoplasm Micrometastasis",
"url": "https://questionsmedicales.fr/mesh/D061206",
"about": {
"@type": "MedicalCondition",
"name": "Micrométastase tumorale",
"code": {
"@type": "MedicalCode",
"code": "D061206",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.727.650.695"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Essaimage tumoral",
"alternateName": "Neoplasm Seeding",
"url": "https://questionsmedicales.fr/mesh/D009366",
"about": {
"@type": "MedicalCondition",
"name": "Essaimage tumoral",
"code": {
"@type": "MedicalCode",
"code": "D009366",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.727.650.830"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Métastases d'origine inconnue",
"alternateName": "Neoplasms, Unknown Primary",
"url": "https://questionsmedicales.fr/mesh/D009382",
"about": {
"@type": "MedicalCondition",
"name": "Métastases d'origine inconnue",
"code": {
"@type": "MedicalCode",
"code": "D009382",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.727.650.895"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Cellules tumorales circulantes",
"alternateName": "Neoplastic Cells, Circulating",
"url": "https://questionsmedicales.fr/mesh/D009360",
"about": {
"@type": "MedicalCondition",
"name": "Cellules tumorales circulantes",
"code": {
"@type": "MedicalCode",
"code": "D009360",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.727.650.900"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Récidive tumorale locale",
"alternateName": "Neoplasm Recurrence, Local",
"url": "https://questionsmedicales.fr/mesh/D009364",
"about": {
"@type": "MedicalCondition",
"name": "Récidive tumorale locale",
"code": {
"@type": "MedicalCode",
"code": "D009364",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.727.655"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Maladie résiduelle",
"alternateName": "Neoplasm, Residual",
"url": "https://questionsmedicales.fr/mesh/D018365",
"about": {
"@type": "MedicalCondition",
"name": "Maladie résiduelle",
"code": {
"@type": "MedicalCode",
"code": "D018365",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.727.700"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Dépendance oncogène",
"alternateName": "Oncogene Addiction",
"url": "https://questionsmedicales.fr/mesh/D000074723",
"about": {
"@type": "MedicalCondition",
"name": "Dépendance oncogène",
"code": {
"@type": "MedicalCode",
"code": "D000074723",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.727.850"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Processus néoplasiques",
"alternateName": "Neoplastic Processes",
"code": {
"@type": "MedicalCode",
"code": "D009385",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Barbara A Centeno",
"url": "https://questionsmedicales.fr/author/Barbara%20A%20Centeno",
"affiliation": {
"@type": "Organization",
"name": "Department of Pathology, Moffitt Cancer Center, Tampa, Florida, USA, Barbara.Centeno@moffitt.org."
}
},
{
"@type": "Person",
"name": "Sarah C Thomas",
"url": "https://questionsmedicales.fr/author/Sarah%20C%20Thomas",
"affiliation": {
"@type": "Organization",
"name": "Office of Chief Medical Examiner, New York, New York, USA."
}
},
{
"@type": "Person",
"name": "Guoqiang Zeng",
"url": "https://questionsmedicales.fr/author/Guoqiang%20Zeng",
"affiliation": {
"@type": "Organization",
"name": "Urological Department, First Hospital of Jilin University, Changchun 130021, Jilin Province, China."
}
},
{
"@type": "Person",
"name": "Honglan Zhou",
"url": "https://questionsmedicales.fr/author/Honglan%20Zhou",
"affiliation": {
"@type": "Organization",
"name": "Urological Department, First Hospital of Jilin University, Changchun 130021, Jilin Province, China."
}
},
{
"@type": "Person",
"name": "Yuantao Wang",
"url": "https://questionsmedicales.fr/author/Yuantao%20Wang",
"affiliation": {
"@type": "Organization",
"name": "Urological Department, First Hospital of Jilin University, Changchun 130021, Jilin Province, China. Electronic address: wangyuantaobs@jlu.edu.cn."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Components of the Complement Cascade Differ in Polycystic Ovary Syndrome.",
"datePublished": "2022-10-13",
"url": "https://questionsmedicales.fr/article/36293087",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms232012232"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cervicovaginal Complement Activation and Microbiota During Pregnancy and in Parturition.",
"datePublished": "2022-07-25",
"url": "https://questionsmedicales.fr/article/35958597",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2022.925630"
}
},
{
"@type": "ScholarlyArticle",
"name": "Complement biomarkers reflect the pathological status of neuromyelitis optica spectrum disorders.",
"datePublished": "2023-03-03",
"url": "https://questionsmedicales.fr/article/36936980",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2023.1090548"
}
},
{
"@type": "ScholarlyArticle",
"name": "Heat-inactivated Factor B inhibits alternative pathway fluid-phase activation and convertase formation on endothelial cell-secreted ultra-large von Willebrand factor strings.",
"datePublished": "2023-04-08",
"url": "https://questionsmedicales.fr/article/37031266",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-023-33007-3"
}
},
{
"@type": "ScholarlyArticle",
"name": "Association of complement components with the risk and severity of NAFLD: A systematic review and meta-analysis.",
"datePublished": "2022-12-07",
"url": "https://questionsmedicales.fr/article/36569882",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2022.1054159"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "États, signes et symptômes pathologiques",
"item": "https://questionsmedicales.fr/mesh/D013568"
},
{
"@type": "ListItem",
"position": 3,
"name": "Processus pathologiques",
"item": "https://questionsmedicales.fr/mesh/D010335"
},
{
"@type": "ListItem",
"position": 4,
"name": "Processus néoplasiques",
"item": "https://questionsmedicales.fr/mesh/D009385"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Processus néoplasiques - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Processus néoplasiques",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-09",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Processus néoplasiques",
"description": "Comment diagnostiquer un cancer ?\nQuels tests sont utilisés pour le dépistage ?\nQu'est-ce qu'une biopsie ?\nQuels sont les marqueurs tumoraux ?\nComment évaluer le stade d'un cancer ?",
"url": "https://questionsmedicales.fr/mesh/D009385?mesh_terms=Complement+Factor+B&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Processus néoplasiques",
"description": "Quels sont les symptômes courants du cancer ?\nComment reconnaître une tumeur ?\nQuels signes indiquent un cancer avancé ?\nLes symptômes varient-ils selon le type de cancer ?\nQu'est-ce que la cachexie ?",
"url": "https://questionsmedicales.fr/mesh/D009385?mesh_terms=Complement+Factor+B&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Processus néoplasiques",
"description": "Comment prévenir le cancer ?\nLe vaccin contre le HPV prévient-il le cancer ?\nQuels aliments aident à prévenir le cancer ?\nL'exercice physique réduit-il le risque de cancer ?\nLe dépistage précoce est-il important ?",
"url": "https://questionsmedicales.fr/mesh/D009385?mesh_terms=Complement+Factor+B&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Processus néoplasiques",
"description": "Quels sont les traitements standards du cancer ?\nQu'est-ce que l'immunothérapie ?\nComment fonctionne la radiothérapie ?\nQuels sont les effets secondaires de la chimiothérapie ?\nQuand est-ce que la chirurgie est nécessaire ?",
"url": "https://questionsmedicales.fr/mesh/D009385?mesh_terms=Complement+Factor+B&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Processus néoplasiques",
"description": "Quelles sont les complications du cancer ?\nComment les métastases affectent-elles le traitement ?\nQu'est-ce que la douleur cancéreuse ?\nLes traitements peuvent-ils causer des complications ?\nComment gérer les effets secondaires des traitements ?",
"url": "https://questionsmedicales.fr/mesh/D009385?mesh_terms=Complement+Factor+B&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Processus néoplasiques",
"description": "Quels sont les principaux facteurs de risque du cancer ?\nL'hérédité joue-t-elle un rôle dans le cancer ?\nLe stress est-il un facteur de risque ?\nL'exposition à des produits chimiques augmente-t-elle le risque ?\nL'alimentation influence-t-elle le risque de cancer ?",
"url": "https://questionsmedicales.fr/mesh/D009385?mesh_terms=Complement+Factor+B&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer un cancer ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des examens cliniques, imageries et biopsies."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le dépistage ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent mammographies, coloscopies et tests sanguins spécifiques."
}
},
{
"@type": "Question",
"name": "Qu'est-ce qu'une biopsie ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une biopsie consiste à prélever un échantillon de tissu pour analyse histologique."
}
},
{
"@type": "Question",
"name": "Quels sont les marqueurs tumoraux ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les marqueurs tumoraux sont des substances produites par les cellules cancéreuses, détectables dans le sang."
}
},
{
"@type": "Question",
"name": "Comment évaluer le stade d'un cancer ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stade est évalué par des examens d'imagerie et des classifications comme TNM."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants du cancer ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fatigue, perte de poids, douleurs et changements cutanés."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une tumeur ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une tumeur peut se manifester par une masse palpable, des douleurs ou des changements fonctionnels."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent un cancer avancé ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent des douleurs persistantes, des saignements inexpliqués et des troubles respiratoires."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type de cancer ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chaque type de cancer présente des symptômes spécifiques selon l'organe touché."
}
},
{
"@type": "Question",
"name": "Qu'est-ce que la cachexie ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "La cachexie est une perte de poids et de masse musculaire souvent associée au cancer."
}
},
{
"@type": "Question",
"name": "Comment prévenir le cancer ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention inclut un mode de vie sain, l'évitement du tabac et des dépistages réguliers."
}
},
{
"@type": "Question",
"name": "Le vaccin contre le HPV prévient-il le cancer ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le vaccin contre le HPV réduit le risque de cancers liés au virus, comme le cancer du col."
}
},
{
"@type": "Question",
"name": "Quels aliments aident à prévenir le cancer ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les fruits, légumes, grains entiers et aliments riches en antioxydants sont bénéfiques."
}
},
{
"@type": "Question",
"name": "L'exercice physique réduit-il le risque de cancer ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier est associé à un risque réduit de plusieurs types de cancer."
}
},
{
"@type": "Question",
"name": "Le dépistage précoce est-il important ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le dépistage précoce permet de détecter le cancer à un stade plus traitable."
}
},
{
"@type": "Question",
"name": "Quels sont les traitements standards du cancer ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent chirurgie, chimiothérapie, radiothérapie et immunothérapie."
}
},
{
"@type": "Question",
"name": "Qu'est-ce que l'immunothérapie ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'immunothérapie utilise le système immunitaire pour combattre les cellules cancéreuses."
}
},
{
"@type": "Question",
"name": "Comment fonctionne la radiothérapie ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La radiothérapie utilise des rayonnements pour détruire les cellules cancéreuses."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires de la chimiothérapie ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires incluent nausées, fatigue, perte de cheveux et infections."
}
},
{
"@type": "Question",
"name": "Quand est-ce que la chirurgie est nécessaire ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La chirurgie est souvent nécessaire pour retirer des tumeurs localisées ou pour un diagnostic."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications du cancer ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent métastases, infections, et effets secondaires des traitements."
}
},
{
"@type": "Question",
"name": "Comment les métastases affectent-elles le traitement ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les métastases compliquent le traitement et peuvent nécessiter des approches plus agressives."
}
},
{
"@type": "Question",
"name": "Qu'est-ce que la douleur cancéreuse ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "La douleur cancéreuse est causée par la tumeur ou les traitements, nécessitant une gestion adéquate."
}
},
{
"@type": "Question",
"name": "Les traitements peuvent-ils causer des complications ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements comme la chimiothérapie peuvent entraîner des complications comme des infections."
}
},
{
"@type": "Question",
"name": "Comment gérer les effets secondaires des traitements ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion inclut des médicaments, des soins de soutien et des conseils nutritionnels."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque du cancer ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent le tabagisme, l'alcool, l'obésité et l'exposition à des agents carcinogènes."
}
},
{
"@type": "Question",
"name": "L'hérédité joue-t-elle un rôle dans le cancer ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de cancer augmentent le risque de certains types de cancer."
}
},
{
"@type": "Question",
"name": "Le stress est-il un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress chronique peut influencer le risque de cancer, bien que les preuves soient variées."
}
},
{
"@type": "Question",
"name": "L'exposition à des produits chimiques augmente-t-elle le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des produits chimiques comme l'amiante ou le benzène est un facteur de risque."
}
},
{
"@type": "Question",
"name": "L'alimentation influence-t-elle le risque de cancer ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en graisses et pauvre en fibres peut augmenter le risque de cancer."
}
}
]
}
]
}
Complement pathway proteins are reported to be increased in polycystic ovary syndrome (PCOS) and may be affected by obesity and insulin resistance. To investigate this, a proteomic analysis of the com...
Vaginal microbiome and the local innate immune defense, including the complement system, contribute to anti- and proinflammatory homeostasis during pregnancy and parturition. The relationship between ...
To study the association of the cervicovaginal microbiota composition to activation and regulation of the complement system during pregnancy and labor....
We recruited women during late pregnancy (weeks 41 + 5 to 42 + 0, n=48) and women in active labor (weeks 38 + 4 to 42 + 2, n=25). Mucosal swabs were taken from the external cervix and lateral fornix o...
The vaginal microbiota was...
These results indicate that bacterial composition of the vaginal microbiota could have a role in the local activation and regulation of complement-mediated inflammation during pregnancy. At the time o...
Complement is involved in the pathogenesis of neuroimmune disease, but the detailed pathological roles of the complement pathway remain incompletely understood. Recently, eculizumab, a humanized anti-...
Defective regulation of the alternative complement pathway (AP) causes excessive activation and promotes the inflammation and renal injury observed in atypical hemolytic-uremic syndrome (aHUS). The us...
It is generally believed that complement system is strongly associated with the risk of nonalcoholic fatty liver disease (NAFLD). However, complement system contains a variety of complement components...
We searched PubMed, Embase, Cochrane Library, Google Scholar, Scopus, and ZhiWang Chinese databases from inception to May 2022 for observational studies reporting the risk of NAFLD with complement com...
We identified 18 studies with a total of 18560 included subjects. According to recent studies, levels of complement component 3 (C3) (mean difference (MD): 0.43, 95% confidence interval (CI) 0.26-0.60...
This meta-analysis demonstrates that an increase in complement components including C3, C5, CFB, and ASP is associated with an increased risk and severity of NAFLD, indicating that they may be good bi...
PROSPERO [https://www.crd.york.ac.uk/PROSPERO/], identifier CRD42022348650....
Numerous publications have underlined the link between complement C5a and the clinical course of COVID-19. We previously reported that levels of C5a remain high in the group of severely ill patients u...
The complement system plays a crucial role in cognitive impairment. The aim of this study is to investigate the correlation between the complement proteins levels in serum astrocyte-derived exosomes (...
In this cross-sectional study, the patients with immune-mediated T1DM were enrolled. Healthy subjects matched for age and sex with T1DM patients were selected as controls. The cognitive function was e...
This study recruited 55 subjects immune-mediated T1DM patients without dementia, including 31 T1DM patients with MCI, 24 T1DM patients without MCI. 33 healthy subjects were enrolled as controls. The r...
The elevated C5b-9 levels in ADEswere significantly associated with theMCI in T1DM patients. The C5b-9 in ADEs may be used as a marker of MCI in T1DM patients....
Sensorineural hearing loss is associated with dysfunction of cochlear cells. Although immune cells play a critical role in maintaining the inner ear microenvironment, the precise immune-related molecu...
C3 glomerulopathy (C3G) and atypical hemolytic uremic syndrome (aHUS) are two rare diseases caused by dysregulated activity of the alternative pathway of complement secondary to the presence of geneti...
The factor XIII (FXIII)-B subunit has a critical function as a carrier protein to stabilize FXIII-A in plasma and supply it to its main substrate, fibrinogen. However, the function of the excess free ...
In the present study, we explored potential interactions of free FXIII-B with complement factors and searched for novel binding partners....
We tested for cofactor activity in the degradation of complement C3b and C4b and used ELISA- and surface plasmon resonance-based binding assays to investigate interactions between FXIII-B and compleme...
FXIII-B did not exhibit cofactor activity in the degradation of C3b and C4b similar to factor H and C4b-binding protein, nor did it bind to complement factors to a relevant extent. Identification of p...
Our study reveals that free FXIII-B has no direct role in regulating the complement system, despite a structural similarity to major complement regulators. Further studies are needed to validate α2MG ...